BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1177 related articles for article (PubMed ID: 21636114)

  • 1. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
    Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
    Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: review of a single-institution experience.
    Ulker V; Kuru O; Numanoglu C; Akbayır O; Polat I; Uhri M
    Arch Gynecol Obstet; 2014 May; 289(5):1087-92. PubMed ID: 24213097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study.
    Minig L; Heitz F; Cibula D; Bakkum-Gamez JN; Germanova A; Dowdy SC; Kalogera E; Zapardiel I; Lindemann K; Harter P; Scambia G; Petrillo M; Zorrero C; Zanagnolo V; Rebollo JMC; du Bois A; Fotopoulou C
    Ann Surg Oncol; 2017 Sep; 24(9):2720-2726. PubMed ID: 28608122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Factors Affecting Lymph Node Metastasis in Clinical Stage I-II Epithelial Ovarian Cancer.
    Erdem B; Yüksel IT; Peker N; Ulukent SC; Aşıcıoğlu O; Özaydin IY; Ülker V; Akbayir O
    Oncol Res Treat; 2018; 41(7-8):444-448. PubMed ID: 29975960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: Hacettepe experience and review of literature.
    Desteli GA; Gultekin M; Usubutun A; Yuce K; Ayhan A
    World J Surg Oncol; 2010 Nov; 8():106. PubMed ID: 21114870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses.
    Bogani G; Tagliabue E; Ditto A; Signorelli M; Martinelli F; Casarin J; Chiappa V; Dondi G; Leone Roberti Maggiore U; Scaffa C; Borghi C; Montanelli L; Lorusso D; Raspagliesi F
    Gynecol Oncol; 2017 Oct; 147(1):61-65. PubMed ID: 28779965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node metastasis in grossly apparent stages I and II epithelial ovarian cancer.
    Nomura H; Tsuda H; Susumu N; Fujii T; Banno K; Kataoka F; Tominaga E; Suzuki A; Chiyoda T; Aoki D
    Int J Gynecol Cancer; 2010 Apr; 20(3):341-5. PubMed ID: 20375794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Lymph Node Metastases in Apparent Early-Stage Low-Grade Epithelial Ovarian Cancer: A Comprehensive Review.
    Lago V; Minig L; Fotopoulou C
    Int J Gynecol Cancer; 2016 Oct; 26(8):1407-14. PubMed ID: 27465900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications.
    Morice P; Joulie F; Camatte S; Atallah D; Rouzier R; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D
    J Am Coll Surg; 2003 Aug; 197(2):198-205. PubMed ID: 12892797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY).
    Uccella S; Nero C; Vizza E; Vargiu V; Corrado G; Bizzarri N; Ghezzi F; Cosentino F; Turco LC; Fagotti A; Scambia G
    Am J Obstet Gynecol; 2019 Oct; 221(4):324.e1-324.e10. PubMed ID: 31082385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary.
    Mueller JJ; Holzapfel M; Han CH; Santos K; Gunderson C; Moore K; Erickson B; Leath CA; Diaz E; Walsh C; Wethington SL; Dejbakhsh SZ; Barakat RR; Gardner GJ; Hyman DM; Soslow RA; Leitao MM
    Int J Gynecol Cancer; 2016 Jan; 26(1):120-4. PubMed ID: 26509849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the optimal lymphadenectomy cut-off value in epithelial ovarian cancer staging surgery utilizing a mathematical model of validation.
    Pereira A; Irishina N; Pérez-Medina T; Magrina JF; Magtibay PM; Kovaleva A; Rodríguez-Tapia A; Iglesias E
    Eur J Surg Oncol; 2013 Mar; 39(3):290-6. PubMed ID: 23290581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
    Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
    Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?
    Bizzarri N; du Bois A; Fruscio R; De Felice F; De Iaco P; Casarin J; Vizza E; Chiantera V; Corrado G; Cianci S; Magni S; Ferrari D; Giuliani D; Harter P; Ataseven B; Bommert M; Perrone AM; Scambia G; Fagotti A
    Gynecol Oncol; 2021 Jan; 160(1):56-63. PubMed ID: 33168305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage- and Histologic Subtype-Dependent Frequency of Lymph Node Metastases in Patients with Epithelial Ovarian Cancer Undergoing Systematic Pelvic and Paraaortic Lymphadenectomy.
    Heitz F; Harter P; Ataseven B; Heikaus S; Schneider S; Prader S; Bommert M; Fisseler-Eckhoff A; Traut A; du Bois A
    Ann Surg Oncol; 2018 Jul; 25(7):2053-2059. PubMed ID: 29633097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and feasibility of robotic-assisted lymph node staging in early-stage ovarian cancer.
    Brown JV; Mendivil AA; Abaid LN; Rettenmaier MA; Micha JP; Wabe MA; Goldstein BH
    Int J Gynecol Cancer; 2014 Oct; 24(8):1493-8. PubMed ID: 25078341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer.
    Yavuzcan A; Baloglu A; Cetinkaya B
    Arch Gynecol Obstet; 2009 Dec; 280(6):939-44. PubMed ID: 19306011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas.
    Cass I; Li AJ; Runowicz CD; Fields AL; Goldberg GL; Leuchter RS; Lagasse LD; Karlan BY
    Gynecol Oncol; 2001 Jan; 80(1):56-61. PubMed ID: 11136570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node metastasis in stages I and II ovarian cancer: a review.
    Kleppe M; Wang T; Van Gorp T; Slangen BF; Kruse AJ; Kruitwagen RF
    Gynecol Oncol; 2011 Dec; 123(3):610-4. PubMed ID: 21982047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.
    Negishi H; Takeda M; Fujimoto T; Todo Y; Ebina Y; Watari H; Yamamoto R; Minakami H; Sakuragi N
    Gynecol Oncol; 2004 Jul; 94(1):161-6. PubMed ID: 15262135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.